SEC Form 4 · accession 0001579618-15-000001

ANI PHARMACEUTICALS INC · ANIP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Tracy Marshbanks

Director

Period of report

Mar 12, 2015

Accepted (ET)

Mar 16, 2015 · 9:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001023024

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 12, 2015	S	143,516	$63.00	D	375,829	I	See Footnote 1
Common Stock^F2	Mar 12, 2015	S	5,978	$63.00	D	15,656	I	See Footnote 2
Common Stock^F3	Mar 12, 2015	S	58,265	$63.00	D	152,579	I	See Footnote 3
Common Stock^F4	Mar 12, 2015	S	2,241	$63.00	D	5,870	I	See Footnote 4

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F11: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F22: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F33: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
F44: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

Remarks

Reporting person disclaims the existence of a "group" and disclaims beneficial ownership of any securities (except to the extent of such Reporting Person's pecuniary interest in such securities) other than any securities reported herein as being directly owned by such Reporting Person and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of any such securities for purpose of Section 26 or any other purpose.